May Webinar: Precision Medicine in Cancer Supportive Care

WEBINAR DETAILS

May 12, 2016, 11am EDT

VIEW  WEBINAR

 

Cancer regimen-related toxicities are often devastating consequences of current chemo- and radiotherapy regimens used for the treatment of malignancies. But not all patients are at equal risk for developing toxicities and, for those who do, the response to specific treatment varies. Risk and response are largely determined by genomic and epigenomic profiles. This symposium will discuss regimen-related toxicities and present examples of how the application of genomics (and epigenomics) can be applied to effectively identify and treat patients at risk.